We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New System Preserves Motion after Spinal Fusion

By HospiMedica staff writers
Posted on 02 Apr 2007
A new system mimics the function of the posterior spine elements, allowing surgeons to decompress and stabilize the impaired posterior spinal segment in patients with two-level disc disease, without sacrificing motion.

The TOPS-on-Fusion system (TOPS) is a total posterior motion preservation device that integrates lumbar fusion with total posterior arthroplasty at two adjacent levels, sharing the loads with the native disc and protecting the anterior column from excessive movements. More...
The device is indicated for L3-L5 and L4-S1 patients where the inferior segment is fused and the superior level is treated with total posterior arthroplasty, and is designed to stabilize (but not fuse) the affected vertebral level to alleviate pain stemming from spinal stenosis with or without degenerative facet arthrosis and spondylolisthesis.

Following a laminectomy and medial facetectomy, the device is affixed to the spine via four pedicle screws using a standard posterior surgical approach. The system effectively replaces the anatomic structures that are removed during the decompression procedure. Internal metal stoppers replace the natural bony elements that served as stoppers during axial rotation. The boot and internal components take the place of the supraspinous ligament, interspinous ligament, and ligamentum flavum in their ability to help control flexion. The TOPS-on-Fusion system is a product of Impliant (Princeton, NJ, USA). The system has received CE Mark approval, and is undergoing clinical trials in the United States.

"It is common to have patients with advanced disc and posterior disease at one level and isolated posterior problems at the adjacent level,” said Dr. Louis Nel, M.D., a senior spine surgeon who performed the procedure at Eugene Marais Hospital (Pretoria, South Africa). "The TOPS-on-Fusion system stabilizes both segments while allowing motion at the level adjacent to fusion by effectively replacing all the posterior structures removed during the decompression. I was very satisfied with the simplicity and ease of the procedure.”


Related Links:
Impliant
Eugene Marais Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.